Cases & Deals

  • Home
  • Practices
  • Purdue Pharma pursues patent infringement suit involving OxyContin(R) against generic drug maker Teva

Share

Purdue Pharma pursues patent infringement suit involving OxyContin(R) against generic drug maker Teva

2014

Client(s) Purdue Pharma L.P.

Jones Day represents Purdue Pharma L.P., The P.F. Laboratories, Inc., and Purdue Pharmaceuticals L.P. in a Hatch-Waxman Act patent infringement litigation matter relating to Teva Pharmaceuticals USA, Inc.'s attempt to market a generic version of Purdue's controlled-release OxyContin(R) pain relief medication.

Purdue Pharma L.P. et al. v. Teva Pharm. USA, Inc., 1:14-cv-02357 (S.D.N.Y.)

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.